Skip to main content
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1997 Feb;88(2):213–217. doi: 10.1111/j.1349-7006.1997.tb00368.x

Altered Expression of γ‐Glutamylcysteine Synthetase, Metallothionein and Topoisomerase I or II during Acquisition of Drug Resistance to Cisplatin in Human Ovarian Cancer Cells

Yoshihiro Kikuchi 1,, Junko Hirata 1, Kenji Yamamoto 1, Kenji Ishii 1, Tsunekazu Kita 1, Kazuya Kudoh 1, Takehiko Tode 1, Ichiro Nagata 1, Ken Taniguchi 2, Michihiko Kuwano 2
PMCID: PMC5921366  PMID: 9119751

Abstract

This study was designed to elucidate the mechanisms of cisplatin (CDDP) resistance using two human ovarian cancer cell lines, KF and TYK, and two CDDP‐resistant lines, KFr and TYK/R, derived from the former lines. KFr and TYK/R showed about 3‐fold higher resistance to the cytotoxic effects of CDDP than their parental lines. They also showed a significant increase in sensitivity to not only etoposide, but also (+)‐(4S)‐4, ll‐diethyl‐4‐hydroxy‐9‐[(4‐piperidino‐piperidino)carbonyloxy]‐lH‐pyrano[3′,4′:6,7]inodolizino[l,2‐b]quinoline‐3,14(4H, 12H)‐dione hydrochloride trihydrate (CPT‐11). Cellular CDDP accumulation levels in KFr and TYK/R were decreased from those of the parental cells. By contrast, the cellular glutathione (GSH) content in KFr cells was 1.7‐fold higher than that in KF, whereas TYK/R cells had a 40% lower content than TYK cells. Cellular mRNA levels of drug‐resistance‐related genes, such as DNA topoisomerase (topo) I and topo II, glutathione S‐transferase‐π (GST‐π;), γ‐glutamylcysteine synthetase (.γ‐GCS), and metallothionein (hMT) genes, were compared between drug‐sensitive KF or TYK and KFr or TYK/R. KFr cells had 8.5‐ and 24.7‐fold higher mRNA levels of γ‐GCS and topo II genes than KF cells while KFr had only a slight increase in GST‐π mRNA level as compared with KF. By contrast, TYK/R cells had 2.9‐ and 1.7‐fold higher hMT and topo I mRNA levels than TYK cells. Acquisition of CDDP resistance in human ovarian cancer cells thus appeared to be related mainly to expression of γ‐GCS, topo II and hMT genes, and partly to that of topo I and GST‐π genes, in addition to a decrease in CDDP accumulation

Keywords: γ‐Glutamylcysteine synthetase, Metallothionein, Topoisomerase, Cisplatin resistance, Human ovarian cancer cell

Full Text

The Full Text of this article is available as a PDF (343.2 KB).

REFERENCES

  • 1. ) Timmer‐Bosscha , H. , Mulder , N. H. and de Vries , E. G. E.Modulation of cis‐diamminedichloroplatinum (II) resistance: a review . Br. J. Cancer , 66 , 227 – 238 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. ) Eastman , A. and Schulte , N.Enhanced DNA repair as a mechanism of resistance to cis‐diamminedichloroplatinum (II) . Biochemistry , 27 , 4730 – 4734 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Chen , G. and Zeller , W. J.In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell line . J, Cancer Res. Clin. Oncol , 116 , 443 – 447 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Sriram , R. , Ali‐Osman , F. , Livingston , R. , Ellis , G. , Needle , M. N. and Stein , D.Modulation of topoisomerase (Topo) II on the kinetics of formation and repair of cisplatinum (cis‐DDP) induced DNA‐interstrand cross links (DNA‐ISC) in human tumor cells sensitive and resistant to cis‐DDP . Proc. Am. Assoc. Cancer Res. , 31 , 335 ( 1990. ). [Google Scholar]
  • 5. ) Waud , W. R. , Harrison , S. D. J. , Gilbert , K. S. , Laster , W. R. J. and Griswold , D. P. J.Antitumor drug cross‐resistance in vivo in a cisplatin‐resistant murine P388 leukemia . Cancer Chemother. Pharmacol , 27 , 456 – 463 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Kotoh , S. , Naito , S. , Yokomizo , A. , Kumazawa , J. , Asakuno , K. , Kohno , K. and Kuwano , M.Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin‐resistant bladder cancer cells . Cancer Res. , 54 , 3248 – 3253 ( 1994. ). [PubMed] [Google Scholar]
  • 7. ) Kikuchi , Y. , Miyauchi , M. , Kizawa , I. , Oomori , K. and Kato , K.Establishment of a cisplatin‐resistant human ovarian cancer cell line . J, Natl Cancer Inst , 77 , 1181 – 1185 ( 1986. ). [PubMed] [Google Scholar]
  • 8. ) Yoshiya , N.Establishment of a cell line from human ovarian cancer (undiiferentiated carcinoma of FIGO classification) and analysis of its cell‐biological characteristics and sensitivity to anticancer drugs . Acta Obstet. Gynaecol, Jpn. , 38 , 1747 – 1753 ( 1986. ) (in Japanese) . [PubMed] [Google Scholar]
  • 9. ) Hirata , J. , Kikuchi , Y. , Kita , T. , Imaizumi , E. , Tode , T. , Ishii , K. , Kudoh , K. and Nagata , I.Modulation of sensitivity of human ovarian cancer cells to cis‐diamminedichloroplatinum (II) by 12‐O‐tetradecanoyl‐13‐acetate and D, L‐buthionine‐S, R‐sulphoximine . Int. J. Cancer , 55 , 521 – 527 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Litterst , C. L. , Gram , T. E. , Dedrick , R. L. , Leroy , A. and Guarino , A. M.Distribution and disposition of platinum following intravenous administration of cis‐diamminedi‐chloroplatinum (II) (NSC1198875) to dogs . Cancer Res. , 36 , 2340 – 2344 ( 1976. ). [PubMed] [Google Scholar]
  • 11. ) Griffith , O. W.Determination of glutathione and glutathione disulfide using glutathione reductase and 2‐vinylpyridine . Anal. Biochem. , 106 , 207 – 212 ( 1980. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Chomoczynski , P. and Sacchi , N.Single‐step method of RNA isolation by acid guanidium thiocyanate‐phenolchloroform extraction . Anal. Biochem. , 162 , 156 – 159 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Krain , M. and Richards , R. I.Human metallothionein genes‐primary structure of the metallothionein‐II gene and related processed gene . Nature , 227 , 680 – 685 ( 1970. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Gipp , J. J. , Chang , C. and Mulcahy , R. T.Cloning and nucleotide sequence of a full‐length cDNA for human liver γ‐glutamylcysteine synthetase . Biochem. Biophys. Res. Commun. , 185 , 29 – 35 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Andrews , P. A. and Howell , S. B.Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance . Cancer Cells , 2 , 35 – 43 ( 1990. ). [PubMed] [Google Scholar]
  • 16. ) Scanlon , K. J. , Kashani‐Sabet , M. , Miyachi , H. , Sowers , L. C. and Rossi , J.Molecular basis of cisplatin‐resistance in human carcinoma: model systems and patients . Anticancer Res. , 9 , 1301 – 1312 ( 1989. ). [PubMed] [Google Scholar]
  • 17. ) Kikuchi , Y. , Iwano , I. , Miyauchi , M. , Kita , T. , Sugita , M. , Tenjin , Y. and Nagata , I.Possible mechanisms of resistance to cis‐diamminedichloroplatinum (II) of human ovarian cancer cells . Jpn. J. Cancer Res. , 81 , 701 – 706 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. ) Godwin , A. K. , Meister , A. , O'Dwyer , P. J. , Huang , C. S. , Hamilton , T. C. and Anderson , M. E.High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis . Proc. Natl. Acad. Sci. USA , 89 , 3070 – 3074 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. ) Saburi , Y. , Nakagawa , M. , Ono , M. , Sakai , M. , Muramatsu , M. , Kohno , K. and Kuwano , M.Increased expression of glutathione S‐transferase gene in cis‐diam‐minedichloroplatinum (II)‐resistant variants of a Chinese hamster ovary cell line . Cancer Res. , 49 , 7020 – 7025 ( 1989. ). [PubMed] [Google Scholar]
  • 20. ) Kasahara , K. , Fujiwara , Y. , Nishio , K. , Ohmori , T. , Sugimoto , Y. , Komiya , K. , Matsuda , T. and Saijo , N.Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin . Cancer Res. , 51 , 3237 – 3242 ( 1991. ). [PubMed] [Google Scholar]
  • 21. ) Schilder , R. J , Hall , L , Monks , A. , Handel , L. M. , Faranc , A. J. , Jr. , Ozols , R. F. , Fojo , A. T. and Hamilton , T. C.Metallothionein gene expression and resistance to cisplatin in human ovarian cancer . Int. J. Cancer , 45 , 416 – 422 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Takano , H. , Kohno , K. , Ono , M. , Uchida , Y. and Kuwano , M.Increased phosphorylation of DNA topoisomerase II in etoposide‐resistant mutants of human cancer KB cells . Cancer Res. , 51 , 3951 – 3957 ( 1991. ). [PubMed] [Google Scholar]
  • 23. ) Matsuno , K. , Kohno , K. , Sato , S. , Uchiumi , T. , Tanimura , H. , Yamada , Y. and Kuwano , M.Enhanced expression of the DNA topoisomerase II gene in response to heat shock stress in human epidermoid cancer KB cells . Cancer Res. , 53 , 1085 – 1090 ( 1993. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES